The influence of MOGAD on diagnosis of multiple sclerosis using MRI

R Geraldes, G Arrambide, B Banwell, À Rovira… - Nature Reviews …, 2024 - nature.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated demyelinating disease that is challenging to differentiate from multiple …

Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands

Y Tomizawa, Y Hoshino, R Kamo, D Cossu… - Frontiers in …, 2023 - frontiersin.org
Introduction Myelin-oligodendrocyte glycoprotein antibody (MOG)–associated disorder
(MOGAD) is a recently identified immune-mediated inflammatory disorder of the central …

CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD: Clinical and Immunologic Follow-Up for 1 Year

JM Cabrera-Maqueda, M Sepulveda… - Neurology …, 2024 - neurology.org
Objectives In MOG antibody-associated disease (MOGAD), relapse prevention and the
treatment approach to refractory symptoms are unknown. We report a patient with refractory …

Advances in the long-term treatment of neuromyelitis optica spectrum disorder

M Anderson, M Levy - Journal of Central Nervous System …, 2024 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neuroinflammatory
disorder with a prevalence of 1-5/100,000 globally, characterized by attacks of the central …

[HTML][HTML] Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes

E Wassmer, C Billaud, M Absoud… - European Journal of …, 2024 - Elsevier
Objectives We aimed to study the risks of relapse and long term disability in children with
non-MS acquired demyelinating syndromes (ADS). Methods In this prospective, multi-centre …

The landscape of PBMCs in AQP4‐IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry

M Yao, W Wang, J Sun, T Guo, J Bian… - CNS Neuroscience …, 2024 - Wiley Online Library
Objectives Data on peripheral blood mononuclear cells (PBMCs) characteristics of
aquaporin‐4 (AQP4)‐IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and …

Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine

GR Dos Passos, T Adoni, MF Mendes… - Arquivos de Neuro …, 2023 - SciELO Brasil
Precision medicine has revolutionized the field of neuroimmunology, with innovative
approaches that characterize diseases based on their biology, deeper understanding of the …

Navigating through the recent diagnostic criteria for MOGAD: challenges and practicalities

O Ciccarelli, AT Toosy, A Thompson, Y Hacohen - Neurology, 2023 - AAN Enterprises
International criteria for the diagnosis of myelin oligodendrocyte glycoprotein–associated
disease (MOGAD) were published in The Lancet Neurology® on January 24, 2023.1 The …

[HTML][HTML] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders

JM Seok, P Waters, MY Jeon, HL Lee… - Annals of laboratory …, 2024 - synapse.koreamed.org
Background The clinical implications of myelin oligodendrocyte glycoprotein autoantibodies
(MOG-Abs) are increasing. Establishing MOG-Ab assays is essential for effectively treating …

Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports

BQ Du, QL Lai, EC Li, MT Cai, GL Fang… - Clinical and …, 2024 - academic.oup.com
The overlapping of two or more types of neural autoantibodies in one patient has
increasingly been documented in recent years. The coexistence of myelin oligodendrocyte …